Tag: p64
Large prospective study demonstrates high efficacy and low mortality rates with...
The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...
High rate of aneurysm occlusion with p64 at mid- and long-term...
Investigators using the p64 Flow Modulation Device (Phenox) for the treatment of unruptured intracranial aneurysms at six centres have revealed that mid- and long-term...
New device is “equivalent to, or better than” known flow diverters...
In the first study to be published reporting on endovascular aneurysm treatment with the p64 flow modulation device (Phenox), Francesco Briganti and colleagues have found that the device provides a safe procedure with no technical complications.
Phenox receives CE mark approval for p64 Flow Modulation Device
The p64 Flow Modulation Device is an intraluminal flow diverter for treatment of complex intracranial aneurysms and dissections.
